Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309263759> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4309263759 endingPage "1028" @default.
- W4309263759 startingPage "1023" @default.
- W4309263759 abstract "Anti-tumor necrosis factor (TNF) antibodies play a major role in treating inflammatory bowel disease (IBD), both in adult and pediatric patients. While there is a large number of studies on efficacy and safety of infliximab in treating children and adolescents with ulcerative colitis (UC), data on adalimumab (ADA) are scarce.Here, we review published case reports, cohort and real-time data, as well as the first randomized trial, ENVISION I, using ADA for treating pediatric UC. Available evidence confirms good efficacy in inducing and maintaining remission in children and adolescents with UC, with even higher response rates compared to adult UC. ENVISION I showed that in UC patients responding to ADA induction therapy, almost half of the patients remained in remission after 52 weeks of therapy on high-dosing ADA (weekly administration). As already well experienced with other biologics, dosing schemes are different between pediatric and adult patients, with children often requiring higher dosing.Further data are required to better understand how to optimize ADA therapy. The present and still-growing evidence places subcutaneous (sc.) anti-TNF-medication as alternative first-line therapy also for pediatric UC. This is also reflected by the preference for sc. medication of adolescent patients allowing less frequent and autonomous drug administration." @default.
- W4309263759 created "2022-11-25" @default.
- W4309263759 creator A5044105377 @default.
- W4309263759 creator A5085197906 @default.
- W4309263759 date "2022-11-21" @default.
- W4309263759 modified "2023-10-03" @default.
- W4309263759 title "A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children" @default.
- W4309263759 cites W1981017999 @default.
- W4309263759 cites W1995681414 @default.
- W4309263759 cites W1996063338 @default.
- W4309263759 cites W2092863985 @default.
- W4309263759 cites W2098373560 @default.
- W4309263759 cites W2146692972 @default.
- W4309263759 cites W2171392253 @default.
- W4309263759 cites W2587130863 @default.
- W4309263759 cites W2749325548 @default.
- W4309263759 cites W2755342707 @default.
- W4309263759 cites W2765131729 @default.
- W4309263759 cites W2766046358 @default.
- W4309263759 cites W2781618914 @default.
- W4309263759 cites W2797152839 @default.
- W4309263759 cites W2800395784 @default.
- W4309263759 cites W2807688850 @default.
- W4309263759 cites W2841623998 @default.
- W4309263759 cites W2889010000 @default.
- W4309263759 cites W2900987894 @default.
- W4309263759 cites W2912684592 @default.
- W4309263759 cites W2943255037 @default.
- W4309263759 cites W2944335283 @default.
- W4309263759 cites W2944596484 @default.
- W4309263759 cites W2986558699 @default.
- W4309263759 cites W3011014362 @default.
- W4309263759 cites W3055936268 @default.
- W4309263759 cites W3114213774 @default.
- W4309263759 cites W3120032252 @default.
- W4309263759 cites W3158974035 @default.
- W4309263759 cites W3175981068 @default.
- W4309263759 cites W3176064512 @default.
- W4309263759 cites W3181344859 @default.
- W4309263759 cites W4210728052 @default.
- W4309263759 cites W4239255546 @default.
- W4309263759 cites W4290666452 @default.
- W4309263759 doi "https://doi.org/10.1080/17474124.2022.2149489" @default.
- W4309263759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36395503" @default.
- W4309263759 hasPublicationYear "2022" @default.
- W4309263759 type Work @default.
- W4309263759 citedByCount "0" @default.
- W4309263759 crossrefType "journal-article" @default.
- W4309263759 hasAuthorship W4309263759A5044105377 @default.
- W4309263759 hasAuthorship W4309263759A5085197906 @default.
- W4309263759 hasConcept C126322002 @default.
- W4309263759 hasConcept C2777138892 @default.
- W4309263759 hasConcept C2777288759 @default.
- W4309263759 hasConcept C2778260677 @default.
- W4309263759 hasConcept C2779134260 @default.
- W4309263759 hasConcept C2780132546 @default.
- W4309263759 hasConcept C2780479503 @default.
- W4309263759 hasConcept C71924100 @default.
- W4309263759 hasConcept C72563966 @default.
- W4309263759 hasConceptScore W4309263759C126322002 @default.
- W4309263759 hasConceptScore W4309263759C2777138892 @default.
- W4309263759 hasConceptScore W4309263759C2777288759 @default.
- W4309263759 hasConceptScore W4309263759C2778260677 @default.
- W4309263759 hasConceptScore W4309263759C2779134260 @default.
- W4309263759 hasConceptScore W4309263759C2780132546 @default.
- W4309263759 hasConceptScore W4309263759C2780479503 @default.
- W4309263759 hasConceptScore W4309263759C71924100 @default.
- W4309263759 hasConceptScore W4309263759C72563966 @default.
- W4309263759 hasIssue "11-12" @default.
- W4309263759 hasLocation W43092637591 @default.
- W4309263759 hasLocation W43092637592 @default.
- W4309263759 hasOpenAccess W4309263759 @default.
- W4309263759 hasPrimaryLocation W43092637591 @default.
- W4309263759 hasRelatedWork W1708680437 @default.
- W4309263759 hasRelatedWork W2187503363 @default.
- W4309263759 hasRelatedWork W2296926020 @default.
- W4309263759 hasRelatedWork W2297514571 @default.
- W4309263759 hasRelatedWork W2945945073 @default.
- W4309263759 hasRelatedWork W2984572983 @default.
- W4309263759 hasRelatedWork W3022383156 @default.
- W4309263759 hasRelatedWork W3135292505 @default.
- W4309263759 hasRelatedWork W4213332249 @default.
- W4309263759 hasRelatedWork W4309263759 @default.
- W4309263759 hasVolume "16" @default.
- W4309263759 isParatext "false" @default.
- W4309263759 isRetracted "false" @default.
- W4309263759 workType "article" @default.